CTOs on the Move

Respicardia

www.respicardia.com

 
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.respicardia.com
  • 12400 Whitewater Dr Suite 150
    Minnetonka, MN USA 55343
  • Phone: 952.540.4470

Executives

Name Title Contact Details

Funding

Respicardia raised $58.5M on 12/19/2017

Similar Companies

Acclarent

Acclarent, Inc. is a medical technology company focused on designing, developing and commercializing technologies that address conditions affecting the ear, nose and throat (ENT). The Company focuses on commercializing its Balloon Sinuplasty devices,

Pointshare Corporation

Pointshare Corporation is a Issaquah, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maxtec.

Maxtec. is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cylex

Cylex is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biodirection

NanoDx Inc. is a privately held medical device company developing novel and rapid point-of-care technologies for the objective diagnosis and management of concussion and other traumatic brain injury (TBI).